Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR‐133a

S Shao, Y Zhang, M Gong, Q Yang… - Oxidative Medicine …, 2021 - Wiley Online Library
Heart failure (HF) is a clinical syndrome caused by impairment of ventricular filling, ejection
of blood, or both and is categorized as HF with reduced ejection fraction (HFrEF) or HF with …

Divergent cardiac and renal effects of miR-181c-5p inhibition in a rodent heart failure model

JRA Boen, AB Gevaert, A Dendooven… - Frontiers in …, 2024 - frontiersin.org
Aims MiR-181c-5p overexpression associates with heart failure (HF) and cardiac damage,
but the underlying pathophysiology remains unclear. This study investigated the effect of …

MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats

HQ Sang, ZM Jiang, QP Zhao, F Xin - Biomedicine & Pharmacotherapy, 2015 - Elsevier
Objective MicroRNAs (miRNAs), a group of small non-coding RNAs that fine tune translation
of multiple target mRNAs, have been implicated in the development and progression of …

Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: A review

Y Kamisah, HH Che Hassan - International Journal of Molecular Sciences, 2023 - mdpi.com
Cardiac remodeling can cause ventricular dysfunction and progress to heart failure, a
cardiovascular disease that claims many lives globally. Ivabradine, a funny channel (I f) …

Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1

S Liu, L Su, J Li, Y Zhang, X Hu, P Wang, P Liu… - Molecular and Cellular …, 2024 - Elsevier
Pathological cardiac hypertrophy often precedes heart failure due to various stimuli, yet
effective clinical interventions remain limited. Recently, microRNAs (miRNAs) have been …

Transgenic expression of miR-133a in the diabetic akita heart prevents cardiac remodeling and cardiomyopathy

TN Kambis, HR Shahshahan, S Kar… - Frontiers in …, 2019 - frontiersin.org
Advanced diabetes mellitus (DM) may have both insulin resistance and deficiency (double
DM) that accelerates diabetic cardiomyopathy (DMCM), a cardiac muscle disorder. Reduced …

Betalain exerts cardioprotective and anti-inflammatory effects against the experimental model of heart failure

Y Gao, X Liang, Z Tian, Y Ma… - Human & Experimental …, 2021 - journals.sagepub.com
Betalain is a natural plant pigment known to elicit various biological activities. However,
studies on the protective effect of betalain against heart failure have not reported yet. The …

[HTML][HTML] Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction

Z Liu, B Tao, S Fan, S Cui, Y Pu, L Qiu, H Xia… - Aging (Albany NY …, 2020 - ncbi.nlm.nih.gov
Background: Numerous studies have highlighted the crucial role of microRNA-145 (miR-
145) in coronary atherosclerosis and myocardial ischemia reperfusion injury. However …

miR-155 modulates high glucose-induced cardiac fibrosis via the Nrf2/HO-1 signaling pathway

Y Li, JZ Duan, Q He, CQ Wang - Molecular Medicine …, 2020 - spandidos-publications.com
Cardiac fibrosis is a major pathological manifestation of diabetic cardiomyopathy, which is a
leading cause of mortality in patients with diabetes. MicroRNA (miR)-155 is upregulated in …

MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats

G Wang, R Wang, Z Ruan, L Liu, Y Li… - Bioscience reports, 2020 - portlandpress.com
The aim of the present study was to determine the effect of microRNA (miR)-132 on cardiac
fibrosis in myocardial infarction (MI)-induced heart failure and angiotensin (Ang) II-treated …